Sarkoidoz: v poiskakh optimal'noy terapii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the current view on sarcoidosis, which is not rare disease now. Today, instead of a pulmonary disease with intrathoracic lymphadenopathy and/or pulmonary dissemination, sarcoidosis is regarded as a multiorgan, multisystem granulomatosis with difficult predictable course. The approaches to the treatment of different variants of sarcoidosis, including use of systemic steroids, essential phospholipids, N-acetylcysteine, methotrexate, etc., are discussed.

Full Text

Restricted Access

References

  1. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(2):149-73.
  2. Gerke AK, Yang M, Tang F, et al. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med 2012; 12(1):19.
  3. Ligon CB, Judson MA. Impact of systemic corticosteroids on healthcare utilization in pateints with sarcoidosis. Am J Med Sci 2011; 341(3):196-201.
  4. Rothkrantz-Kos S, Drent M, Vuil H, et al. Decreased redox state in red blood cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19(2):114-20.
  5. Lenz AG, Hinze-Heyn H, Schneider A, et al. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases. Respir Med 2004;98(8):737-45.
  6. Markart P, Luboeinski T, Korfei M, et al. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Antioxid Redox Signal 2009;11(2):227-40.
  7. Baradzina H, Kamishnikov V. Essential phospholipids in pulmonary sarcoidosis. Eur Resp J 2008;32(52):Ref.P3434.
  8. Баранова О.П., Доценко Е.К., Бакланова О.Э. Эффективность применения N-ацетилцистеина у больных саркоидозом легких III-IV стадии. Сборник трудов конгресса. XIX Национальный конгресс по болезням органов дыхания / Под ред. акад. А.Г. Чучалина. М., 2009. С. 212-13.
  9. Борисов С.Е., Купавцева Е.А. Лечение саркоидоза / Сборник научных трудов, посвященный 80-летию института. М., 1998. C. 62-68.
  10. Визель А.А., Насретдинова Г.Р., Исламова Л.В., Визель Е.А. Оценка эффективности различных режимов лечения больных вновь выявленным саркоидозом в Республике Татарстан// Пробл. туб. 2006. № 4. С.19-23.
  11. Визель И.Ю., Визель А.А. Итоги одногодичного наблюдения больных с гистологически верифицированным саркоидозом // Казанский мед. журн. 2010. № XCI(6). С. 724-29.
  12. Drent M, Jacobs JA, de Vries J, et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13(6):1338-44.
  13. Londner C, Zendah I, Freynet O, et al. Treatment of sarcoidosis. Rev Med Intern 2011;32(2):109-13.
  14. Mihailovic-Vucinic V, Jovanovic D. Pulmonary sarcoidosis. Clin Chest Med 2008; 29(3):459-73.
  15. Patterson KC, Hogarth K, Husain AN, et al. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Transl Res 2012; Apr 10. [Epub ahead of print].
  16. Wells AU, Hirani N and on behalf of the British Thoracic Society Interstitial Lung. Interstitial lung disease guideline: the British and the Irish Thoracic Society Thoracic Society of Australia and New Zealand Thoracic Society in collaboration with the Thoracic Society of Australia and Disease Guideline Group, a subgroup of the British Thoracic Society Standards. Thorax 2008;63;v1-v58.
  17. McKinzie BP, Bullington WM, Mazur JE, Judson M.A. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci 2009;339(1):1-4.
  18. Дауров Б.И. Проблема реактивации саркоидоза и возможности ее решения. Дисс. док. мед. наук. М, 2004. 48 с.
  19. Rizzato G, Montemurro L, Colombo P. The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 1998;15(1):52-8.
  20. Аминева Л.Х. Диагностика, лечение и диспансерное наблюдение больных саркоидозом. Дис. канд. мед. наук. Уфа, 1999. 26 с.
  21. Скрипина А.Г., Визель И.Ю. Фактор некроза опухоли альфа при саркоидозе: от патогенеза к лечению // Вестник современной клинической медицины. 2011. № 4(3). С. 24-28.
  22. Meyersburg D, Schon MP, Bertsch HP, Seitz CS. Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy. Hautarzt 2011;62(9):691-95.
  23. Саркоидоз: Монография / Под ред. А.А. Визеля. М., 2010. 416 с.
  24. Саркоидоз: учебно-методическое пособие для слушателей послевузовского и дополнительного профессионального образования / Под ред. А.Г. Чучалина. Казань, 2010. 58 c.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies